Value of determining the cerebrospinal fluid protein markers of amyloidosis and neurodegeneration in the diagnosis of vascular and neurodegenerative cognitive impairments
The article presents data on different forms of moderate cognitive impairments (MCI) and the specific features of their transformation to dementia. Cerebrospinal fluid (CSF) was investigated in 60 patients with the amnestic and neurodynamic types of MCI, in 15 patients with vascular dementia (VD), 5...
Main Authors: | Vladimir Yuryevich Lobzin, A Yu Emelin, M M Odinak, L A Alekseeva, N E Monakhova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2013-12-01
|
Series: | Неврология, нейропсихиатрия, психосоматика |
Subjects: | |
Online Access: | https://nnp.ima-press.net/nnp/article/view/264 |
Similar Items
-
Cerebrospinal fluid Aβ40 improves the interpretation of Aβ42 concentration for diagnosing Alzheimer’s disease.
by: Aline eDorey, et al.
Published: (2015-11-01) -
Aquaporin-4 cerebrospinal fluid levels are higher in neurodegenerative dementia: looking at glymphatic system dysregulation
by: Andrea Arighi, et al.
Published: (2022-09-01) -
Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease—From Brain Starch to Bench and Bedside
by: Matthias Pawlowski, et al.
Published: (2017-07-01) -
Cognitive impairments in cerebrovascular disease: What is between health and dementia?
by: A. Yu. Emelin
Published: (2015-03-01) -
A Comparison of Cerebrospinal Fluid Beta-Amyloid and Tau in Idiopathic Normal Pressure Hydrocephalus and Neurodegenerative Dementias
by: Said HM, et al.
Published: (2022-04-01)